5.38 Interest of Early Determination of Bone Marrow Minimal Residual Disease by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: the Experience of the CLL2007FMP, an Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine, Cyclophosphamide, and Rituximab versus Fludarabine, Cyclophosphamide, and MabCampath in Previously Untreated B-Chronic Lymphocytic Leukemia Patients

✍ Scribed by Remi Letestu; Stephane Leprêtre; Christine Arnoulet; Lucille Baseggio; Lydia Campos; Bernard Chatelain; Bernard Drenou; Marie-Christine Jacob; Eric Legac; Magali Le Garff-Tavernier; Michel Ticchioni; Nelly Robillard; Roselyne Delepine; Vincent Levy; Sandrine Katsahian; Veronique Leblond; Florence Cymbalista; Pierre Feugier

• Book ID: 119218982
• Publisher: Elsevier
• Year: 2011
• Tongue: English
• Weight: 81 KB
• Volume: 11
• Category: Article
• ISSN: 2152-2650
• DOI: 10.1016/j.clml.2011.09.192